Vera Therapeutics VERA D&A

D&A at other companies

Vertex PharmaceuticalsVRTX

$55.9M+15.5%

Travere Therapeutics, Inc.TVTX

$25.21M+96.9%

Aurinia PharmaceuticalsAUPH

$4.83M-0.6%

Climb Bio, Inc.CLYM

$38K—

Jade BiosciencesJBIO

$9K+125%

Viridian Therapeutics, Inc.VRDN

$117K+3.5%

FAQ

What is Vera Therapeutics's D&A?

Vera Therapeutics (VERA) reported D&A of $140K in Q1 2026.

How has Vera Therapeutics's D&A changed year-over-year?

Vera Therapeutics's D&A increased by 64.7% year-over-year, from $85K to $140K.

What is the long-term trend for Vera Therapeutics's D&A?

Over 4 years (2021 to 2025), Vera Therapeutics's D&A has grown at a 27.7% compound annual growth rate (CAGR), from $176K to $468K.

What does D&A mean?

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.